Dr. Tharmaratnam is Novotech’s Chief Executive Officer and Chairman, bringing more than 30 years of experience across the global CRO and life sciences industry. He has served on the Novotech Board since 2021 and has been closely involved in guiding the company’s strategic direction and growth. A UK-trained physician specializing in anesthesia and critical care, Anand previously spent 23 years at Quintiles and its successor organization, IQVIA, including 10 years on their global executive committees as Head of Asia and Japan. As CEO and Chairman, he is leading Novotech into its next phase of global expansion, strengthening scientific capabilities, and delivering high-quality outcomes for biotech clients worldwide.